Calendar of Events

The conference will focus on advances in assessment and understanding of developmental and reproductive toxicology, and application in risk assessment practice. The program is now available for both the CE Day and ASM on the meeting website.

The conference will include presentations from numerous distinguished invited speakers, including plenary speaker Dr Paul Foster (Former Chief of Toxicology Branch of the NTP).

Presentation themes include:

• Recent changes in OECD reproduction/developmental test protocols: for better or worse, risk assessment implications!
• Predictability (or otherwise) of adverse endocrine disruptive effects suggested by in vitro assays and whether/how to incorporate into risk assessment?
• Relevance of non-mammalian assays to identify mammalian development and reproductive toxicants
• The use of in vitro endocrine activity data for identifying and classifying chemical hazards in Australia
• Environmental exposures and low birth weight; what is the evidence telling us?
• Understanding reproductive/developmental chemical and botanical hazards
• Recent developmental investigations of an herbal product: being 'all natural' does not necessarily mean safe!
• Neurobehavioural toxicity testing
• Mode of action of thalidomide.

We hope to welcome you in Melbourne soon!

Lexis invites all the participants from around the world to attend Pain Medicine 2019 conference to be held in Toronto, Canada on August 30-31, 2019 at 9:00 am.
Our committees have worked to ensure a varied program for Pain Specialists, Anaesthesiologists, Chiropractors, Pharmacists, Acupuncture Doctors, Physiotherapists, Neuropsychologists, Cancer Specialists, Orthopaedicians, Professors/Associate Professors/Assistant Professors/Students in Pain Management, Deans / Vice Presidents of Pain Management Department, Directors / Managers & Business Intelligence Experts of Pharma Industries, Post Doctorals and Researchers in Pain Management, Pharmacology Department. And for any other information regarding the conference, kindly review the descriptions on the website. It includes all the details on the sessions that are planned for these 2 days. The purpose of this meeting is to deliver a comprehensive overview of the latest information, insights and practices in Pain Medicine.

When and Where?
Date: Friday, August 30-31, 2019
Time: 9:00 am – 06:00 pm
Location: Toronto, Canada

Our conversations have highlighted that although a strong commercial opportunity exists, there are critical areas of basic science that need addressing including study design to elucidate host-microbiome interactions, selecting the right tools to make clear correlations between microbial dysbiosis and skin disease and standardization of sample collection and analysis.

Early booking and group discounts are available. Visit the website or email info@microbiome-movement.com to learn more.

Venue Details: The Westin San Diego, 400 West Broadway, San Diego, 92101, United States

Join us and discover:

Take advantage of this unrivalled learning and networking opportunity packed with content and dedicated interactive formats to ensure you leave equipped with the connections and takeaways to enhance the predictive success of your preclinical 3D models.

URLs:

Tickets:

Theme 1: Cancer Hazard Identification for Nongenotoxic Substances:
Too Much or too Little?

The goal of this symposium is to share insights on how available human data can be interpreted with regards to understanding the health-impacts of benzene and setting of a safe exposure level.
The target audience of this symposium are interested stakeholders from academia, regulatory authorities and industry that work on the health and safety assessment of benzene.

A formal registration form will then be sent at in July.

Join the Digital Pharma Team for the 13th Digital Pharma East at the Pennsylvania Convention Center in Philadelphia, September 17–20, and over 1000 attendees with the knowledge to de-risk proposals and ensure internal buy-in to guarantee approval and commercial success of digital business plans.

Venue Details: Pennsylvania Convention Center, 1101 Arch Street, Philadelphia, 19107, United States

Abstract submission deadline is May 1, 2019, with late breaking abstracts due by Aug 29, 2019.

Apply for Travel Awards Today

This year there will be an expanded number of $750.00 travel awards for students, postdocs and new investigators. The application is due on May 1, 2019.

On behalf of the Safety Pharmacology Society (SPS) Board of Directors and Officers, we would like to invite you to attend the 2019 SPS Annual Meeting at the Centre de Convencions Internacional de Barcelona in the beautiful, art-inspired city of Barcelona, Spain.

Over the last few months, the 2019 Program and CE Committees have been hard at work organizing scientific programs and courses that include topics of interest to SPS Members and colleagues. The 2019 Scientific Program features a diverse range of scientific sessions organized into two concurrent themed tracks covering issues such as Cardiac Safety Concerns, New Models: In Vitro, Hot Topics in CNS, Immune Related Adverse Events, Thoughts on Translation, Personalized Medicine, Clinician Perspectives on Safety Pharmacology, Artificial Intelligence/In Silico, Biomarkers – The Far Reaching Value, Early Derisking Strategy and Techniques, Strategies for Getting to FIH and Beyond – Efficiently and Safely, Revisiting S7A and S7B and much more! This will ensure attendees can stay abreast of new content and developments in key areas of interest.

The meeting also offers a broad Continuing Education program both on an introductory level as well as advanced courses for the expert. A program outline is now available on the 2019 Meeting website. For those interested in increasing their knowledge, recognition and expertise in the field, we will also be holding the 2019 certification exam for the Diplomate in Safety Pharmacology on September 22 and invite all interested SPS members to consider sitting the exam this year.

In an effort to support attendance from our younger colleagues, please note that there are opportunities for Student and Jr. Investigator Travel and poster awards. We encourage you to submit an abstract for presentation as a poster to be featured in our Exhibit Hall. From these submissions a variety will be selected for short oral communications. The deadline to submit an abstract for presentation is June 15, 2019.

We also would like to highlight our Exhibit Hall, which will feature over 50 vendors offering direct access to CROs, as well as a variety of service and technology providers exhibiting the latest technology and developments relevant to the field.

We cordially invite you to become a member of our Society, become involved in our ongoing scientific activities and join us in Barcelona, Spain for our 2019 Annual Meeting this Fall!

"The live format of this educational activity will be accredited with CPD Credits"

The conference is for worldwide healthcare professionals influencing patient care. This year guarantees an innovative networking approach which has never been experienced before. Additionally, a research platform for rising stars to share their valuable cutting-edge information to reinforce Clinical Strategies. Meet the future as we pledge to change the landscape of Clinical Trials by bringing the World-wide Clinical Specialists to Prague, Czech Republic

Conference Highlights: Drug Development, Pre-Clinical Evaluations, Clinical Trials & Toxicology, Pharmacokinetic Studies, Bioavailability and Bio Equivalence, Clinical Trials Phases, Adverse Effects, Patient Centric Clinical Trials, Adaptive Clinical Trials, Enrolment Planning and Patient Recruitment, Artificial Intelligence in Clinical Trials, Clinical Trials Auditing, Pharmacovigilance and Risk Management, Protocol Study, Good Clinical and Pharmacovigilance Practices, Clinical Trials in Cardiology, Clinical Trials in Neurology, Clinical Trials in Dermatology, Clinical Trials Oncology
CRO, Sponsorship & Outsourcing for Clinical Trials, Clinical research and Case Reports, Clinical Research and Statistics, Significance of Clinical Scientist in PV, Clinical information management, Ethical Committee and Institutional Review Board, Significance of Pharmacovigilance, Pharmacovigilance Consultants, Regulatory Board

Let's meet in the city of Prague, Czech Republic

Related Clinical Trials Conferences | Clinical Trial Conferences | Pharmacovigilance Conferences | Clinical Trials Congress |Clinical Trials Meetings | Medical Conferences | Pharmacology Conferences | Clinical Research Conferences

Come join us in September 2019 and; thoroughly understand the latest developments in the biobanking industry; network with the industry experts and key opinion leaders; gain insight into how the biobanking industry at the forefront at driving precision medicine and enhancing research and discover ‘Drone4Care’, how drone delivery of biosamples can be a reality.

Benefits of attending:

• Hear from UK Biobank on the continual impact of GDPR on the biobanking landscape

• Gain insight from the global biobank collaboration societies of ESBB and ISBER, see how you can place your biobank on the international stage

BOOK BY 30TH APRIL AND SAVE £400
BOOK BY 31ST MAY AND SAVE £300
BOOK BY THE 28TH JUNE AND SAVE £200

• Natural Diseases of Rodents
• Medical Device Pathology in Rodent Models
• Nanoparticle-related Pathology in Rodent Models
• Toxicology for Pathologists
• Emerging Topics in Clinical Pathology

Against this background, the 17th biannual meeting of the International Neurotoxicology Association will discuss what could be achieved so far with respect to the overall theme of “Translational Neurotoxicology”. The scientific program will especially focus on research related to the translation of recent neuroscience knowledge into neurotoxicity research as well as on ways, how recent development in neurotoxicity testing can be translated and included in human risk assessment procedures.

A consistent theme through the meeting will be that of the ‘Next Generation’. This will include the next generation of joint repair technologies, of investigative techniques, and importantly, of researchers. Our interest in the future of the ICRS has been highlighted by our previous development of the ICRS NextGen group – recognizing and promoting the next generation of cartilage physicians and scientists, who ultimately will lead the ICRS into the future. As such, you will see many mid-career researchers and surgeons share their experiences and latest work, guided by the sage wisdom of our mentors throughout the congress program.

US EPA
Research Triangle Park, NC

For 2019 we include a special focus on transforming RandD and clinical trials, demonstrating how patient-led design reduces costs and accelerates the development of patient-relevant solutions.

Gain insights on:

On the other, successful innovation is currently inhibited by our failure to master the basics - with inconsistent multichannel interaction and a low cultural acceptance of non-traditional methods, whether it's digital or education-led initiatives.

The orphan drug market is continuously growing and is expected to reach $176 billion by 2020, with a CGR of 10.5% just for orphan drugs – this is twice the growth rate of the overall prescription drug market (5.3% CGR from 2014-2020). By 2020, orphan drugs are set to account for 19% of global prescription sales.

The 2019 agenda features various key presentations by leading solution providers, biotechnology companies, clinical researchers, regulatory professionals and charity leaders discussing possible ways to accelerate orphan drug development and access to rare disease patients, including the introduction of recent technologies and products to help aid the access of orphan drugs.

PLUS AN INTERACTIVE HALF-DAY POST-CONFERENCE WORKSHOP
Thursday 17th October 2019
A deep dive into strategies for accelerating patient access of orphan drugs
Workshop Leader: Workshop Leaders: Solange Corriol-Rohou, Senior Director Regulatory Affairs & Policy Europe, AstraZeneca
Cecile Ollivier, Chief Operating Officer, Aparito

WHO SHOULD ATTEND?

CEOs, CSOs, Vice Presidents, Directors, Heads, Principals working in:

Medical Affairs, Medical Advisory, Clinical Operations, Rare Disease Research, Patient Advocacy, Commercial Officer, Orphan Drug Therapeutics, Healthcare, Regulatory Affairs, Rare Disease Charity Officers

For more details and to register or this event, visit the website at http://www.orphandrugs.co.uk/toxicologywl

EARLY BIRD-RATES

- BOOK BY 30TH AUGUST AND SAVE £200

SOCIAL MEDIA HANDLES

Event Hashtag: SMiOrphanDrugs

Gene Therapy for Rare Disorders Europe is the uniquely focused conference uniting industry leaders to discuss the late-stage challenges that need to be overcome to deliver more gene therapies to market.

Early booking and group discounts apply. Please visit the website for more information.

The Congress hosts high-level speakers hailing from big pharma, biotech, academia, regulatory bodies, investor groups, and associations, discussing topics representing key challenges within their industries, new data, case studies and research.

Join thousands of attendees across the three days to maximise your time with four conferences in one. Discover new innovations and build new business relations on our exhibition floor with solution providers, biotech industry leaders and world class pharma professionals.

The Festival of Biologics' mission is to bring together the full value chains from the antibodies, immunotherapy, clinical trials and biosimilars industries together, located in Basel - a major life science hub. The Festival of Biologics takes place 15-17 October, join us this year to discover, develop, and get to market.

NSF International
Ann Arbor, MI

There is increasing interest in the use of 3D systems in both discovery and applied research. But how appropriate or successful are the use of these systems in these areas and what still needs to be improved in order for such approaches to be more widely adopted? The SLAS 2019 Advanced 3D Human Models and High-Content Analysis Symposium focuses on four distinct, yet interrelated, aspects. You will hear from experts in their fields about current and near-future enabling technologies, applications of such systems in high-throughput screening, advances in imaging and analysis of data generated in these systems and the expansion into novel model systems. This symposium aims to include not just the current successes but also what the current limitations and opportunities are in this rapidly expanding field.

Registering for NMD will help you to:

Join Biogen, Acceleron Pharma, Roche, Voyager and more at NMD this October - don’t miss this opportunity to unite with like-minded peers to overcome your roadblocks preventing you developing truly transformative neuromuscular treatments.

- Address pharma-physician disconnect in Europe with the EMA
- Understand considerations from European Health Technology Assessment Bodies when assessing the value of medicines for NASH with NICE
- Review regulatory guidance for NASH with compensated cirrhosis with the FDA

Join 80+ other NASH drug developers to navigate solutions for these and 10+ other rate limiting factors as the first NASH therapies receive approval.

Venue Details: The Waldorf Hilton, London, Aldwych, London, WC2B 4DD, United Kingdom

Date and Time: On Wednesday October 23, 2019 at 9:00 am ends Friday October 25, 2019 at 4:30 pm

Over 40 presentations, case studies and panel discussions focusing on the key issues in cell line optimisation, 3D cell culture and bioprocessing technologies

Cell Line Development
PART 1: Early Cell Culture and Cell Line Engineering
PART 2: 3D Cell Culture Models and Applications
Process Development: Upstream Bioprocessing and Analytics
Cell Line Development: Late Stage Cell Line Development, Stability, Data and Assay Data Development
Cell Culture and Downstream Bioprocessing
14 pre-scheduled one to one meetings, exhibition and informal networking opportunities

The inaugural Inflammasome Therapeutics Summit (ITS) is industry's first dedicated discussion and networking forum focused on bringing together inflammasome thought-leaders to share the latest scientific progress and address the current challenges drug developers are facing. With the mission to bridge the gap between research and drug development and develop clinically effective candidates for inflammatory driven diseases.

Developed in combination with experts from Nodthera, Pfizer and IFM Therapeutics and other leading organisations, this industry focused forum allows you to determine which diseases the inflammasome is driving and therefore which have the most therapeutic potential commercially and clinically, review the basic biology and mechanisms of action and the use of biomarkers and endpoints for increased efficacy in clinical trials to name a few.

Salient Features:
Keynote Speech of Toxicology Experts
50+ plenary talks by researchers all over the globe
Opportunity to meet global experts in Environmental Toxicology
Impressive Exhibitions
Posters, e-posters and video presentation by research community
International Certification by Organizing Committee
Live Streaming of your presentation through our websites and YouTube
Publishing accepted abstract in International Journals

USEFUL LINKS:

https://bit.ly/2YaxEtd prev conf agenda

Understanding risk assessment is one thing. Communicating about risk is another. The Society of Toxicology of Canada is partnering with experts for an interactive, hands-on workshop that will boost your skills in both areas.

• Stay on top of the science.

• Gain a deeper understanding of risk assessment methods.

• Maximize the value of toxicology studies in characterizing risk.

• Encourage the use of sound science in risk-based decision-making.

• Apply practical tools for communicating your work.

We will have over 600 end users representing internationally renowned research And academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.

Discussion Workshop and Breakfast: 10x Genomics Platform, Technologies Overview and Updates on The Human Cell Atlas Project.

Healthcare focus: benchmarking RNA Seq sequencing technologies in the clinic, biopsies and single cell analyses to improve stratification of patient and diagnosis.

We will have over 600 end users representing internationally renowned research & academic institutions, clinical research institutions, healthcare organisations as well as leading pharmaceutical and biotech companies.

Including 2 interactive streams:

However, despite the rise in new products and services that claim to target the microbiome and improve health across adult and infant populations, there are fundamental questions surrounding the functional, clinical and practical applicability of microbiome-directed research that currently remains unresolved.

Group discounts, start-up and early booking rates are available. Please visit the website for full pricing information.

For sponsorship/exhibition opportunities please get in touch. Contact data as well as the sponsorship brochure can be found on www.mrna-conference.com.

The 25th annual BIO-Europe event is the largest biotechnology partnering conference held in Europe. Over 4,350 global decision makers from biotechnology, pharma and finance annually attend BIO-Europe to identify new business opportunities and develop strategic relationships. Business development executives and dealmakers consider BIO-Europe a must-attend event and an effective business strategy enabling them to meet and present to numerous potential partners. BIO-Europe features the industry’s most advanced web-based partnering system enabling delegates from all parts of the biotechnology value chain to quickly identify, engage and enter into strategic relationships that drive their business successfully forward.
BIO-Europe's world-class workshops, panels and active exhibition along with thousands of prescheduled one-to-one meetings make this event an unrivaled forum for companies across the biotech value chain to meet and do business.

Venue Details: Hamburg Messe, Messeplatz 1, Hamburg, 20357, Germany

Date and Time: On Monday November 11, 2019 at 7:00 am ends Wednesday November 13, 2019 at 6:00 pm

Over two days delegates have the opportunity to debate on burning issues in the industry, learn from top executives and visionaries who are driving the industry, and network with key decision makers for future business opportunities and collaboration.

For sponsorship / exhibition enquiries, please contact Joe Hames via email: joe.hames@ft.com

Vascular Biology 2019 focuses on entailing several interactive scientific sessions. It also offers an enthusiastic opportunity for the growing generations occupied in various researches to improve their abilities in the field.

- Discover the Importance of Gathering Real World Evidence for Development and Launch of New Complement Therapeutics
- Modulate the Alternative Pathway with a Diverse Pipeline of Targets and Modalities
- Hear Clinical Trial Experience to Accelerate your Complement Therapeutics Through the Clinic
- Discover How to Create Translatable Complement Assays
- Improve Translational Biomarker

Attend this meeting to gain clear clinical understanding of the potential role of complement in common indications and identify which indication will be the next big opportunity for complement-based therapeutics.

The 40th Annual Meeting will be at the JW Marriott Desert Ridge in Phoenix, Arizona in 2019.

The Annual Meeting is the heart and soul of the College, a venue for discussing emerging trends in the field of toxicology, networking with friends and colleagues, and professional development. The program is designed by and for members with the goal of providing excellent quality scientific and regulatory content that is directly applicable to the practice of toxicology. The American College of Toxicology is a professional society of a size and culture ideal for scientists of all career stages seeking continuing education, novel and new ideas and strategies, and personal interactions with speakers, other members and guests, and exhibitors.

The 40th Annual Meeting will include a wide-ranging scientific program, a 40th Annual Meeting opening presentation followed by a welcome reception and dinner, the popular traditional poster session reception, awards ceremony and luncheon, distinguished plenary speakers, and networking events. The ACT Annual Meeting offers a unique opportunity for toxicologists preparing for the challenges and decisions that will affect public health and safety in years to come.

ExL’s Pain Management Summit, created based off the former annual Human Abuse Liability Summit, will serve as a platform for professionals in the pain industry to discuss the latest trends in analgesic developments, including the newest progress in abuse-resistant technologies, cannabinoids and marijuana for pain management and treatment of abuse disorders, non-opioid pain drugs, and other therapeutics. It will also explore other issues contributing to the ongoing opioid crisis, including opioid guideline myths, inappropriate treatment approaches, and the transition from oxycodone overdoses to fentanyl and heroin overdoses.

Probiotics-2019 mainly showcases comprehensive approaches in research and usage of probiotics. This Conference revolves around the novel discovery and development. The conference includes Keynote lectures by eminent personalities from around the world in addition to contributed papers both oral and poster presentations.

Please mail us at: probiotics@madridge.com
Submit your abstracts at: https://probiotics.madridge.com/abstract-submission
Registration site: https://probiotics.madridge.com/register

For the 2nd year, network with the KOLs and RNA pioneers, to gain a comprehensive understanding on how to translate the first generation of RNA targeted small molecules into the clinic, stimulate the discussion of successfully targeting RNA via interfering with RNA-protein interactions and seize the therapeutic opportunity in hand by re-defining the undruggable nature of RNA.

Pharma Meeting & Expo 2019 focuses on Drug Discovery & Designing, Drug Delivery Research and Technologies, Pharmacovigilance, Pharmaceutics and Pharmacokinetics, Pharma Market Research, Pharmaceutical Manufacturing and many more. Meet your target market with individuals from around the globe concentrated on finding out about Pharma, this is your single best chance to achieve the biggest array of members in our Pharma conference.

The 8th annual PREDiCT: Tumour Models London will return this December with a fresh speaker faculty to help you benchmark your oncology model selection strategy and target validation. With the rise of immuno-oncology, model requirements, target validation and the importance of tumour micro-environment are key to clinical success. The 3-days summit will provide you with real world data from a selected model experts, including Merck Healthcare KGaA, MedImmune, Kymab, Leiden University, Basilea Pharmaceutica for practical insights.

Join this community to meet 100+ like-minded translational, in vivo and pharmacology scientists to discuss how to enhance predictiveness and translatability of your preclinical models.

Venue Details: DoubleTree by Hilton Hotel London - Tower of London, 7 Pepys Street, London, EC3N 4AF, United Kingdom

Date and Time: On Wednesday December 04, 2019 at 9:00 am ends Friday December 06, 2019 at 5:00 pm

- Increased perspective from CROs
- Representation from regulatory authorities
- Functional implementation of TMF systems
- Risk-based monitoring and processes
- Exploring functional areas and their teams
- Innovations and advancements in technology
- Collaboration with clinical sites

Venue Details: Sheraton Orlando Lake Buena Vista Resort, 12205 South Apopka Vineland Road, Orlando, 32836, United States

Date and Time: On Tuesday January 21, 2020 at 9:00 am ends Thursday January 23, 2020 at 5:00 pm

It takes immense pleasure to invite you to attend 4th International Conference on Chronic Diseases (Chronic Diseases 2020) scheduled to be held in Paris, France during February 17-18, 2020.
Chronic Diseases 2020 is a global event focusing on the immense knowledge and major advances in the rapidly emerging fields of chronic diseases by attracting experts and professionals across the universe.

Visit: https://chronicdiseases.cmesociety.com/

Obesity-2020 conference includes Plenary lectures, Keynote lectures and short courses by eminent personalities from around the world in addition to contributed papers both oral and poster presentations.

The theme of the Conference is “Science and education for action against HPV”. Through workshops, lectures, oral and poster sessions presenting the latest research results, the program will cover papillomavirus (PV)-related topics from basic science to global health impact. We will be paying special attention to HPV prevention and control in populations that are most vulnerable to HPV disease worldwide, including those in Low- and Middle-Income Countries.

Our overarching theme will be harnessing the power of innovation from HPV research to deliver global prevention and control of HPV-related disease.

See you at IPVC 2020!

The unique scientific program of the Congress will bring you the latest updates in the field of autoimmune diseases, presented by the world's leading experts, while at the same time providing an amazing stage for young upcoming talents to present their research to a first-rate audience.

Established by Professor Yehuda Shoenfeld, the congress constitutes a network of international leaders on immunology, rheumatology and related fields, all of whom contribute their unique and diverse knowledge to the "family of autoimmunity."

SLAS Europe 2020 provides a unique combination of education, access to innovative technologies and intelligent peer networking, delivering unmatched value for professionals and students looking to discover the latest life sciences technologies and how they can be applied to drive research objectives.